Related Articles

• A population‑based study of outcomes in patients with surgically resected non‑small cell lung cancer with anaplastic lymphoma kinase‑rearranged mutations: A matched‑pair study
• Quantitative volumetric assessment of the solid portion percentage on CT images to predict ROS1/ALK rearrangements in lung adenocarcinomas
• ALK‑positive locally advanced lung cancer in a patient who achieved long‑term complete response with crizotinib: A case report
• The efficacy of immune checkpoint inhibitors in advanced non‑small cell lung cancer harboring driver mutations
• Identification of anaplastic lymphoma kinase fusions in clear cell renal cell carcinoma